Chronic Kidney Disease Trial, Recruiting NCT00327860 Sponsor: Johns Hopkins Bloomberg School of Public Health Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT00327860
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 1 to 16 years (for Cohorts 1 and 2), children aged 6 months to 16 years (for Cohort 3), or young people aged 16 to 22 years (for Cohort 4)
  • People with a measured level of kidney function (called GFR) that falls within a specific range depending on which cohort — the trial site can confirm which range applies (confirm with trial site)
  • People who are willing and able to give their agreement to take part, including a parent or guardian providing consent for younger children
  • For Cohort 3 specifically: children whose kidney disease is not caused by a condition affecting the kidney's filtering units (non-glomerular diagnosis) and whose kidney disease has lasted less than 5 years

Who may not be able to join:

  • People who have had an organ transplant other than a kidney, or a bone marrow or stem cell transplant
  • People who have been diagnosed with cancer and are currently receiving treatment, or who finished cancer treatment within the past 12 months
  • People who are still being monitored for heart-related effects from past cancer treatments (such as certain chemotherapy drugs)
  • People with HIV who still have a detectable level of the virus in their blood despite taking HIV medication
  • People who are currently pregnant or have been pregnant in the past 12 months
  • People who would not be able to complete the main parts of data collection for the study
  • People who are not fluent in English or Spanish
  • People whose family plans to move away from any participating trial location (note: transfer to another participating site may be possible if a family moves)
  • People with moderate to severe heart structure problems present from birth
  • People with a genetic condition that affects the brain or nervous system (for example, Down syndrome)
  • People with a history of severe to profound intellectual disability, meaning an IQ below 40, major difficulties with everyday functioning, or inability to carry out basic self-care independently
  • For Cohort 3 specifically: children who are expected to need kidney replacement therapy (such as dialysis or a transplant) within 6 months of joining the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Susan Furth, MD, PhD, Children's Hospital of Philadelphia

Phone: 215-590-2449

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Johns Hopkins Bloomberg School of Public Health
Registry
ClinicalTrials.gov
Start date
1 October 2003
Est. completion
1 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Time to Kidney Replacement Therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov